Clinical factors associated with hepatitis B screening and vaccination in high-risk adults

Table 4 Other medical conditions

	Screening cohort				Vaccination cohort
Comorbidity	Entire screening cohort (n = 999)	Screened for HBV (n = 556)	Not screened for HBV (n = 443)	P-value	Entire vaccination cohort (n = 556)	Vaccinated against HBV (n = 242)	Not vaccinated against HBV (n = 314)	P-value
Acute liver failure	0.4%	0.4%	0.5%	0.782	0.4%	0.4%	0.3%	0.597
Dyslipidemia	43.2%	41.9%	44.9%	0.373	41.9%	38.8%	44.3%	0.231
Hypertension	59.6%	63.0%	55.3%	0.017	62.9%	68.2%	58.9%	0.031
Coronary artery disease	21.1%	24.3%	17.2%	0.008	24.3%	26.0%	22.9%	0.455
Chronic heart failure	10.2%	12.2%	7.7%	0.024	12.2%	11.6%	12.7%	0.775
Chronic obstructive pulmonary disease	5.6%	5.6%	5.6%	0.927	5.6%	4.1%	6.7%	0.265
Peripheral arterial disease	5.2%	6.1%	4.1%	0.191	6.1%	4.5%	7.3%	0.239
Cerebrovascular accident	7.2%	8.6%	5.4%	0.067	8.6%	11.2%	6.7%	0.088
Psychiatric disorder	10.0%	9.2%	11.1%	0.378	9.2%	8.7%	9.6%	0.836
Current tobacco user	6.6%	4.9%	8.8%	0.018	4.9%	3.7%	5.7%	0.370
Current Alcohol use	29.0%	31.3%	26.2%	0.090	31.3%	29.8%	32.5%	0.551
Cancer (any)	18.7%	19.1%	18.3%	0.816	19.1%	12.8%	23.9%	0.001